Defining the Temporal Changes in the Acute Phase Response During Graded Exercise: A Prospective Study
Launched by VANDERBILT UNIVERSITY MEDICAL CENTER · Jan 5, 2018
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Injury, ranging from a paper cut that barely splits the skin to a high-speed motor vehicle accident that rips through muscle and bone, causes a disruption of tissue compartments. This breach of compartments disposes tissue to four principle problems: 1) bleeding, 2) susceptibility to infection, 3) hypoxia, and 4) tissue dysfunction. The acute phase response (APR) is the physiologic system that resolves these four problems of injury. It is divided into two temporally distinct phases: survival and repair. The survival phase utilizes coagulation and inflammation to temporarily seal off breache...
Gender
ALL
Eligibility criteria
- • Arm 1: 20-minute graded exercise Inclusion criteria
- • Healthy individuals (male or female) aged 18-29
- • Regular participation (at least 2 times per week) in moderate intensity exercise
- • BMI between 18.5 and 30.0
- • Exclusion criteria
- • Pre-existing health conditions or injuries that may limit the ability to safely participate in exercise
- • Acute disease process such as an infection, broken bone, or asthma attack
- • Chronic or recent use (within the last 10 days) of any anticoagulant medication or NSAID
- • Pregnant women
- • Recent inpatient admission within the last six months
- • History of smoking or illicit drug use
- • Arm 2: Marathon participation Inclusion criteria
- • Healthy individuals (male or female) aged 18-49
- • In training to complete a marathon (individuals already planning on running a marathon and training accordingly for it)
- • BMI between 18.5 and 30.0
- • Exclusion criteria
- • Pre-existing health conditions or injuries that may limit the ability to safely participate in exercise
- • Acute disease process such as an infection, broken bone, or asthma attack
- • Chronic or recent use (within the last 10 days) of any anticoagulant medication or NSAID
- • Pregnant women
- • Recent inpatient admission within the last six months
- • History of smoking or illicit drug use
About Vanderbilt University Medical Center
Vanderbilt University Medical Center (VUMC) is a leading academic medical center located in Nashville, Tennessee, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, VUMC integrates cutting-edge scientific inquiry with patient-centered care, supporting a diverse array of studies aimed at enhancing medical knowledge and improving treatment outcomes. With a robust infrastructure and a multidisciplinary team of experts, VUMC fosters collaboration across various fields, ensuring the highest standards of safety and ethical considerations in its research endeavors. Through its dedication to medical discovery and education, VUMC plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nashville, Tennessee, United States
Patients applied
Trial Officials
Jonathan Schoenecker, MD, PhD
Principal Investigator
Vanderbilt Orthopaedics
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials